However, experts caution that the findings are preliminary and do not mean patients should start stocking up on the products.

"They should not substitute but complement standard cancer care," said Bruce D. Cheson, head of hematology at the Lombardi Comprehensive Cancer Center and Georgetown University Hospital. He was not involved in the studies.